Jennifer E. Cook
Independent Non-Executive DirectorMs. Jennifer E. Cook, M.B.A., M.S., serves as Advisor at GV Management Company, LLC. She serves as Advisor of Verana Health, Inc. She serves as a Member of Strategic Advisory Board at Deep Genomics Inc. She is Director of Gyroscope Therapeutics Limited. Ms. Cook serves as an Independent Director of Ambys Medicines, Inc. Ms. Cook serves as Independent Non-Executive Director at Jazz Pharmaceuticals plc since December 01, 2020. Ms. Cook is the Owner of Jennifer Cook Consulting. Ms. Cook serves as an Independent Director at BridgeBio Pharma, Inc. since December 2019. She has been an Independent Director at Denali Therapeutics Inc. November 6, 2018. She is a Non-Executive Director of Gyroscope Therapeutics Holdings Plc since November 2020. Ms. Cook was the Chief Executive Officer at GRAIL, Inc. since January 2, 2018 until June 2019. Prior to that, Ms. Cook was at Roche Pharmaceuticals/Genentech where she held a number of senior management positions covering the full lifecycle of product development and commercialization. From 2010 to 2013, she oversaw Genentech's U.S. Immunology and Ophthalmology Business Unit and from 2013 to 2016, she led Roche's European commercial business. From January 2017 to December 2017, Ms. Cook served as Senior Vice President and Global Head of Clinical Operations for Roche Pharmaceuticals. From September 2013 to December 2016, Ms. Cook served as Head of Region Europe Pharma for Roche Pharmaceuticals. In 2016, Ms. Cook was recognized as Woman of the Year by the Healthcare Businesswoman's Association. She serves as an advisor at Google Ventures. From July 2010 to September 2013, Ms. Cook served as the Senior Vice President and Business Unit Head Immunology and Ophthalmology for Genentech Inc. Ms. Cook served as Vice President of Product Portfolio Management of Genentech Inc. Ms. Cook served as Vice President of Market Development of Genentech, Inc. since January 9, 2006. She was responsible for managing five distinct organizations: Market Planning, Forecasting and Business Analysis, Pricing and Publication Strategy, International Operations and Commercial Communications of Genentech, Inc. She joined Genentech in 1997. Ms. Cook served at Genentech in pre-clinical development from 1987 to 1992. She worked at Prizm Pharmaceuticals in product development, business development and project management. Ms. Cook served positions of increasing responsibility in the Commercial Operations group and also served as Senior Director of Market Development since 1997. Ms. Cook holds a Bachelor of Arts in Human Biology, Master of Science in Biology from Stanford University and a Master of Business Administration at the Haas School of Business at University of California, Berkeley.
Positions
- Company NameJazz Pharmaceuticals plcStock CodeJAZZPositionIndependent Non-Executive DirectorColleagues
- BCBruce C. CozaddCo-Founder & Chairman
- RDRenee D. GalaPresident, CEO & Director
- PLPhilip L. JohnsonExecutive VP & CFO
- NMNeena M. PatilExecutive VP & Chief Legal Officer
- RIRobert IannoneExecutive VP, Chief Medical Officer and Global Head of Research & Development
- HAHeather Ann McSharryIndependent Director
- JEJennifer E. CookIndependent Non-Executive Director
- PTPatrick T. KennedyIndependent Director
- Company NameDenali Therapeutics Inc.Stock CodeDNLIPositionIndependent DirectorColleagues
- RJRyan J. WattsCo-Founder, President, CEO & Director
- JCJulian Charles BakerIndependent Chairperson
- AOAlexander O. SchuthCo-Founder, CFO, COO & Secretary
- DADana AndersenChief Technical and Manufacturing Officer
- JLJoe LewcockChief Scientific Officer
- CWChris WalshGeneral Counsel
- JTJay T. FlatleyIndependent Director
- PSPeter S. KleinIndependent Director
